Cargando…
A Novel, Rapid, and Low-Volume Assay for Therapeutic Drug Monitoring of Posaconazole and Other Long-Chain Azole-Class Antifungal Drugs
Clinicians need a better way to accurately monitor the concentration of antimicrobials in patient samples. In this report, we describe a novel, low-sample-volume method to monitor the azole-class antifungal drug posaconazole, as well as certain other long-chain azole-class antifungal drugs in human...
Autores principales: | Wiedman, Gregory R., Zhao, Yanan, Perlin, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300689/ https://www.ncbi.nlm.nih.gov/pubmed/30567902 http://dx.doi.org/10.1128/mSphere.00623-18 |
Ejemplares similares
-
An Aptamer-Based Biosensor for the Azole Class of Antifungal Drugs
por: Wiedman, Gregory R., et al.
Publicado: (2017) -
In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis
por: de Macedo-Silva, Sara Teixeira, et al.
Publicado: (2013) -
Acidic/Alkaline Stress Mediates Responses to Azole Drugs and Oxidative Stress in Aspergillus fumigatus
por: Song, Jinxing, et al.
Publicado: (2022) -
Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
por: Zhang, Yong-Qiang, et al.
Publicado: (2010) -
High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
por: Schauwvlieghe, Alexander F. A. D., et al.
Publicado: (2019)